The Valley Desk

NCT06777316 · Interventional trial

A Study of an FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors

Overall registry status Active not recruiting

Phase 1 · Phase 2

Conditions Advanced Solid Tumors, Cholangiocarcinoma, FGFR2 Gene Amplification, FGFR2 Gene Fusion/Rearrangement, FGFR2 Gene Short Variants, FGFR2 Genetic Alterations, FGFR3 Gene Amplification, FGFR3 Gene Fusion/Rearrangement, FGFR3 Gene Short Variants, FGFR3 Genetic Alterations, Intrahepatic Cholangiocarcinoma (Icc), Other Solid Tumors, Adult

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov